Three Epstein–Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints
- 31 August 2009
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 28 (45) , 3997-4008
- https://doi.org/10.1038/onc.2009.258
Abstract
Epstein–Barr virus (EBV) has been implicated in the pathogenesis of human malignancies, but its contribution to tumorigenesis is not well understood. EBV carriage is associated with increased genomic instability in Burkitt's lymphoma, suggesting that viral products may induce this tumor phenotype. Using a panel of transfected sublines of the B-lymphoma line BJAB expressing the viral genes associated with latent infection, we show that the EBV nuclear antigens, EBNA-1 and EBNA-3C, and the latent membrane protein 1, LMP-1, independently promote genomic instability, as detected by nonclonal chromosomal aberrations, DNA breaks and phosphorylation of histone H2AX. EBNA-1 promotes the generation of DNA damage by inducing reactive oxygen species (ROS), whereas DNA repair is inhibited in LMP-1-expressing cells through downregulation of the DNA damage-sensing kinase, ataxia telangiectasia mutated (ATM), reduction of phosphorylation of its downstream targets Chk2 and inactivation of the G2 checkpoint. EBNA-3C enhances the propagation of damaged DNA through inactivation of the mitotic spindle checkpoint and transcriptional downregulation of BubR1. Thus, multiple cellular functions involved in the maintenance of genome integrity seem to be independently targeted by EBV, pointing to the induction of genomic instability as a critical event in viral oncogenesis.Keywords
This publication has 55 references indexed in Scilit:
- The ATM tumour suppressor gene is down‐regulated in EBV‐associated nasopharyngeal carcinomaThe Journal of Pathology, 2008
- Epstein-Barr Virus Latent Membrane Protein 1 Represses DNA Repair through the PI3K/Akt/FOXO3a Pathway in Human Epithelial CellsJournal of Virology, 2008
- Down‐regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivationThe Journal of Pathology, 2007
- The ATM/ATR Signaling Effector Chk2 Is Targeted by Epstein-Barr Virus Nuclear Antigen 3C To Release the G 2 /M Cell Cycle BlockJournal of Virology, 2007
- The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanismsOral Oncology, 2005
- Cryptic deletion involving the ATM locus at 11q22.3∼q23.1 in B-cell chronic lymphocytic leukemia and related disordersCancer Genetics and Cytogenetics, 2004
- Reactive Oxygen Species Are Downstream Products of TRAF-mediated Signal TransductionJournal of Biological Chemistry, 2001
- Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathwayOncogene, 1999
- Expression of the Epstein-Barr virus (EBV)-encoded membrane antigen (LMP) increases the stimulatory capacity of EBV-negative B lymphoma lines in allogeneic mixed lymphocyte culturesEuropean Journal of Immunology, 1990
- Effect of the ebna‐2 gene on the surface antigen phenotype of transfected ebv‐negative B‐lymphoma linesInternational Journal of Cancer, 1990